IFNA1 and COVID-19: A strength of our study was the ability to perform a comprehensive analysis of both BAB and NAB to IFN‐I in a large number of COVID‐19 patients including a detailed assessment of antibody specificity and influence of auto‐IFN antibodies on biochemical and hematological parameters associated with high risks for severe COVID‐19.